HOTH - Hoth Therapeutics expands IP portfolio with novel Alzheimer's disease treatment
Hoth Therapeutics ([[HOTH]] +16.2%) has filed a provisional patent application with the United States Patent and Trademark Office for the use of one of its current portfolio therapeutics to treat and prevent Alzheimer's disease.The company has also secured an exclusive license agreement with respect to the use of this drug for other indications.The update comes a day after the company announced the successful completion of a pre-IND meeting with the U.S. FDA regarding the company's development plan for their skin disorder treatment HT-001.
For further details see:
Hoth Therapeutics expands IP portfolio with novel Alzheimer's disease treatment